Gates Foundation to fund trial of long-awaited new tuberculosis vaccine candidate
A tuberculosis vaccine under development by the Gates Foundation could reduce TB by 50%. "It's a really big deal."
Read The StoryHealth
The latest developments affecting patients and practitioners. Sign up for our Morning Rounds newsletter to get the latest health and medicine news in your inbox.
STAT Plus: After late start, Eli Lilly has the momentum in battle for $30 billion weight loss market
STAT Plus: The cancer drug shortage isn’t new — and neither are the solutions: ‘It’s like Groundhog Day’
When young people survive cancer, their mental-health struggles are often just beginning
STAT Plus: Ozempic 3.0? Lilly’s ‘triple-G’ drug shows biggest weight loss yet in mid-stage trial
All Coverage
advertisement
